Sustained Regression of Hydroxycarbamide Induced Actinic Keratoses after Switching to Anagrelide

Sustained Regression of Hydroxycarbamide Induced Actinic Keratoses after Switching to Anagrelide

Hydroxycarbamide (HC) is the first-line treatment for certain myeloproliferative neoplasms, such as polycythemia vera and essential thrombocytosis (ET). In a subset of these patients long-term treatment with HC can result in the development of confluent actinic keratoses (AK) followed by invasive ke...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgios Gaitanis, Dora Gougopoulou, Eleni Kapsali, Ioannis D. Bassukas
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2018/2874012
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items